Research out of China found that the pairing proved to be more accurate in identifying cancer in nonmass-like lesions.

This is the eighth clearance in the past three years for Hyperfine's Swoop system, company officials said Monday. 

Researchers from Case Western Reserve University are commissioning a study to determine if a novel MRI technique can predict the effectiveness of chemotherapy in treating breast cancer.

A new AI model helped researchers identify a relationship between background parenchyma enhancement on breast MRI exams and breast cancer risk.

The findings were reached using an analytic hierarchy process, which can help physicians review options with patients who have never experienced either exam.

The task force cited insufficient evidence as the driver behind the decision to forego recommending supplemental screening. 

Researchers suggested these findings could be used as a noninvasive tool in creating more personalized treatment options for patients facing a cancer diagnosis that is invasive in nature. 

“These evidence-based updates should spur more-informed doctor-patient conversations and help providers save more lives," the document's lead author said.